| Autor: |
Pucci P; School of Life, Health & Chemical Sciences, The Open University, Walton Hall, Milton Keynes, Buckinghamshire, MK7 6AA, UK.; Present address: Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, CB20QQ, UK., Venalainen E; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada., Alborelli I; Institute of Pathology, University Hospital Basel, Basel 4031, Switzerland., Quagliata L; Global Head of Medical Affairs, Clinical NGS & Oncology Division, Life Sciences Solutions, Thermo Fisher Scientific, Baarerstrasse, Switzerland., Hawkes C; School of Life, Health & Chemical Sciences, The Open University, Walton Hall, Milton Keynes, Buckinghamshire, MK7 6AA, UK., Mather R; School of Life, Health & Chemical Sciences, The Open University, Walton Hall, Milton Keynes, Buckinghamshire, MK7 6AA, UK., Romero I; School of Life, Health & Chemical Sciences, The Open University, Walton Hall, Milton Keynes, Buckinghamshire, MK7 6AA, UK., Rigas SH; School of Life, Health & Chemical Sciences, The Open University, Walton Hall, Milton Keynes, Buckinghamshire, MK7 6AA, UK., Wang Y; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada.; The Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC V6H 3Z6, Canada.; Department of Urologic Sciences, University of British Columbia, Vancouver, BC V6T 1Z4, Canada., Crea F; School of Life, Health & Chemical Sciences, The Open University, Walton Hall, Milton Keynes, Buckinghamshire, MK7 6AA, UK.; Experimental Therapeutics, BC Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada. |
